HEOR, Epidemiology & Market Access

Our HEOR, Epidemiology, and Market Access research has impacted health care decision making around the globe. We regularly collaborate with our clients to develop and implement HEOR strategies to support pharmaceutical products throughout their life cycles. Our expertise includes comprehensive research capabilities, defined by cutting-edge methodologies that draw on diverse data sources from US and global markets.

We consult on cutting-edge issues at the forefront of health care. Across a broad range of treatments, our innovations in interactive analytics and data visualization provide solutions to our clients’ most complex problems.

Our interdisciplinary team includes health care specialists across our offices in North America, Europe, and Asia, with advanced degrees and expertise in health economics, econometrics, biostatistics, epidemiology, psychometrics, medicine, pharmacy, and health policy.

We have a large network of academic experts, payer experts, and key opinion leaders at leading academic and medical institutions who collaborate in the development of state-of-the-art solutions for our clients.

In addition to our HEOR, Epidemiology, and Market Access capabilities, we have a robust Health Care Policy practice